Neurocrine Biosciences

Patent cliffs & loss of exclusivity

Neurocrine Biosciences is a neuroscience-focused biopharmaceutical company based in San Diego, dedicated to discovering and developing treatments for patients with neurological, psychiatric and endocrine disorders. Founded in 1992, its marketed medicines include INGREZZA and CRENESSITY.

Company

AngelList URLhttps://angel.co/neurocrine-biosciences
CAGE Code5H9C3
Legal NameNeurocrine Biosciences, Inc.
Company Operating StatusActive
Crunchbase URLhttps://www.crunchbase.com/organization/neurocrine-biosciences
Email format{f}{last}
Facebook URLhttps://www.facebook.com/neurocrine/
Fax Number(858) 617-7602

10 upcoming patent cliffs

DrugIngredientTypeCliff
  1. INGREZZAVALBENAZINE TOSYLATESmall mol.Aug 2040
  2. INGREZZAVALBENAZINE TOSYLATESmall mol.Aug 2040
  3. INGREZZAVALBENAZINE TOSYLATESmall mol.Aug 2040
  4. INGREZZA SPRINKLEVALBENAZINE TOSYLATESmall mol.Aug 2040
  5. INGREZZA SPRINKLEVALBENAZINE TOSYLATESmall mol.Aug 2040
  6. INGREZZA SPRINKLEVALBENAZINE TOSYLATESmall mol.Aug 2040
  7. CRENESSITYCRINECERFONTSmall mol.Jan 2043
  8. CRENESSITYCRINECERFONTSmall mol.Jan 2043
  9. CRENESSITYCRINECERFONTSmall mol.Jan 2043
  10. CRENESSITYCRINECERFONTSmall mol.Jan 2043

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.